Besponsa

Besponsa

Basic Prescribing Info
Contents
Inotuzumab ozogamicin
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FB01 - inotuzumab ozogamicin ; Belongs to the class of CD22 (Clusters of Differentiation 22) inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in